UT-MD Anderson Cancer Center: AACR - Trio of Studies Highlights Promising Early Results With New Cancer Therapies and Targets
April 10, 2024
April 10, 2024
HOUSTON, Texas, April 10 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
MD Anderson researchers share clinical data from novel combinations, a new antibody-drug conjugate and a trial of molecularly selected patients
* * *
Three early-phase clinical studies presented by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR . . .
* * *
MD Anderson researchers share clinical data from novel combinations, a new antibody-drug conjugate and a trial of molecularly selected patients
* * *
Three early-phase clinical studies presented by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR . . .